1 Article by Willie O Siu
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.
Psychedelic medicine (New Rochelle, N.Y.) – March 01, 2024
Summary
A significant shift in attitudes is emerging among American psychiatrists regarding the use of hallucinogens. A recent survey revealed that 81% believe these psychedelics hold promise for treating psychiatric conditions, with many planning to incorporate psychedelic-assisted therapy into their practice, pending regulatory approval.
Abstract
Psilocybin, a classic hallucinogen, may eventually be approved by the United States Food and Drug Administration for treatment-resistant depression...